Organization Overview
Historical Acquisition Tree
Alternative names
Key: Infinity Pharmaceuticals, Inc. (1) Acquired (9)
Key: Infinity Pharmaceuticals, Inc. (10) Acquired (9)
atezolizumab (Tecentriq) (1 trial)
azacitidine (vidaza) (1 trial)
bevacizumab (avastin) (1 trial)
Key: Infinity Pharmaceuticals, Inc. (6) Acquired (3)
Adenocarcinoma (Phase 1)
Adrenocortical Carcinoma (Phase 1)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 1)
Carcinoma, Transitional Cell (Phase 2)
Chondrosarcoma (Phase 2)
Gastrointestinal Stromal Tumors (Phase 3)
Head and Neck Neoplasms (Phase 1)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Lymphoid (Phase 2)
Liposarcoma (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Lymphoma, T-Cell (Phase 1)
Melanoma (Phase 2)
Mesothelioma (Phase 1)
Multiple Myeloma (Phase 1)
Neoplasms (Phase 1)
Neoplasms, Plasma Cell (Phase 1)
Neoplasms, Squamous Cell (Phase 1)
Pancreatic Neoplasms (Phase 2)
Primary Myelofibrosis (Phase 2)
Prostatic Neoplasms (Phase 2)
Sarcoma (Phase 1)
Triple Negative Breast Neoplasms (Phase 2)